Antiphospholipid syndrome breakthrough: Cell-surface targets identified, opening path to therapies
Driven by anti-vaxxers, measles outbreaks cost everyone money
12 March 2021Artificial intelligence calculates suicide attempt risk
12 March 2021Antiphospholipid syndrome breakthrough: Cell-surface targets identified, opening path to therapies
A team of researchers affiliated with multiple institutions in Germany and the U.S. have found a cell-surface target for autoantibodies targeting phospholipids (aPL) that contribute to antiphospholipid syndrome (APS). In their paper published in the journal Science, the group describes how they used mouse models of APS with aPL-induced fetal loss and thrombosis to study the connection between the factors that contribute to APS.
